¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â Á¦15ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ : 2023-09-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â Á¦15ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ : 2023-09-16
±³À°ÀÏÀÚ : 2023-09-16
±³À°Àå¼Ò : ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ

±³À°ÁÖÁ¦ : 2023³â Á¦15ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ

´ã´çÀÚ : ÀÌÇý¿ø
¿¬¶ôó : 042-600-6456

À̸ÞÀÏ : office.ksnd@gmail.com

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í »çÀüµî·Ï(ÁØȸ¿ø 3¸¸¿ø, Á¤È¸¿ø/ÀÌ»çÁø 5¸¸¿ø), ´çÀϵî·Ï(ÁØȸ¿ø 5¸¸¿ø, Á¤È¸¿ø/ÀÌ»çÁø 7¸¸¿ø), ºñȸ¿ø(ÁØȸ¿ø±Þ 8¸¸¿ø, Á¤È¸¿ø±Þ 12¸¸¿ø)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:00~09:20 Registration ()

±âŸ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:20~09:30 Opening Remark ¹¬ÀÎÈñ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:30~09:50 Recent advances in biomarkers and therapeutics for AD °í¼ºÈ£(ÇѾçÀÇ´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:50~10:10 Updates in Parkinson ±èÇÑÁØ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:10~10:30 RNA-binding protein and phase separation in ALS ±è±â¿µ(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:30~10:50 Recent trends in Alzheimer R&D ±è¿µ¼ö(¿¬¼¼´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:50~11:10 Current trends and challenges in basic and translational research in Parkinson¡¯s disease ÀÌ¿¬Á¾(¼º±Õ°üÀÇ´ë)

ÈÞ½Ä 09¿ù 16ÀÏ 11:10~11:20 Break ()

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 11:20~12:00 Development of patient-specific diagnosis and treatment for rare degenerative diseases: from bench to bedside ÃÖº´¿Á(¼º±Õ°üÀÇ´ë)

½Ä»ç 09¿ù 16ÀÏ 12:00~13:00 Á¡½É ½Ä»ç ()

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 13:00~13:20 HIFU-responsive multifunctional nanoparticle for the treatment of Parkinson¡¯s disease ±è¿øÁ¾(POSTECH)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 13:00~13:20 Acetylated tau: A missing link between brain injury and Alzheimer¡¯s disease ½Å¹Î±Ô(¼­¿ï´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 13:20~13:40 Strategies for simulating and overcoming human blood-brain barrier ¹ÚÅÂÀº(UNIST)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 13:20~13:40 How do misfolded proteins cause neurodegenerative diseases?: from molecules to drug discovery ¹ÚÇýÁø(KAIST)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 13:40~14:00 BBB-bypassing transcranial route for brain drug delivery °í¿µÅ¹(°¡Ãµ´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 13:40~14:00 Reciprocal relationship between biomolecular condensates and proteostasis ±Ç¿µ´ë(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 14:00~14:20 Super-selective brain delivery of a therapeutic antibody and its therapeutic application in AD ÀÌÀçö(IMNEWRUN)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 14:00~14:20 Functional brain organoid-based precision medicine platform for neurodegenerative diseases ¹ÚÁ¾Âù(¼º±Õ°ü´ë)

±âŸ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:20~15:00 Guided Poster Session ÇмúÀ§¿ø()

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 15:00~15:20 Applying genomics and transcriptomics for advancements in Alzheimer¡¯s disease research ¹Ú¿µÈ£(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 15:00~15:20 The evolving role of biomarkers in early and prodromal Parkinson¡¯s disease ÀÌÁö¿µ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 15:20~15:40 Anti-inflammatory clearance of amyloid beta for Alzheimer¡¯s disease ±èÂùÇõ(KAIST)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 15:20~15:40 Novel pathological model system for Parkinson¡¯s disease ¿À¿äÇÑ(ÇѾçÀÇ´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 15:40~16:00 Phase-I clinical trial of antibody targeting lysine-280 acetylated tau for Alzheimer¡¯s disease À±½Â¿ë(¿ï»êÀÇ´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 15:40~16:00 TGF¥â signaling in the pathogenesis and treatment of peripheral neuropathy È«¿µºó(µ¿¾ÆÀÇ´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 16:00~16:20 Regional amyloid-tau interaction model for Alzheimer¡¯s disease ¼ºÁØ°æ(°í·Á´ë)

±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 16:00~16:20 White matter matters: The role of glia in white matter degeneration ÀÌÇö°æ(Baylor College Med.)

ÈÞ½Ä 09¿ù 16ÀÏ 16:20~16:30 Break ()

±âŸ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 16:30~17:20 Oral Presentation Session 1 ±èÀ±°æ(KIST)

±âŸ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 16:30~17:20 Oral Presentation Session 2 ÀÌÈ£¿ø(°æºÏÀÇ´ë)

±âŸ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 17:20~17:30 Award & Closing ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â Á¦15ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ : 2023-09-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦5ȸ ¼øõÇâ´ëÇб³ ºÎ¼Ó õ¾Èº´¿ø ³»°úÇб³½Ç ¿¬¼ö°­Á : 1Â÷ Áø·áÀǸ¦ À§ÇÑ ÃÖ½ÅÁö°ß ¾÷µ¥ÀÌÆ® : 2023-09-16
´ÙÀ½±Û ´ëÇÑÅëÁõÇÐȸ È£³²Áöȸ Áý´ãȸ(°ñ´Ù°øÁõ, ¸¶¾à¼º ÁøÅëÁ¦, µÎ°æºÎÅëÁõ, Ç㸮ÅëÁõ) : 2023-09-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
294 °æ±â ´ëÇÑ°³¿øÀÇÇùÀÇȸ °­¿øÁöȸ ½ÉÆ÷Áö¿ò : 2018-08-18 0 622 2018-08-08
293 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-17 0 1,086 2018-08-08
292 ¼­¿ï °æÈñ´ëÇб³º´¿ø Á¦11ȸ »êºÎÀΰú-¼Ò¾Æû¼Ò³â°ú ¼±»ý´Ôµé°ú ÇÔ²²ÇÏ´Â ¿ù·ÊÁý´ãȸ : 2018-08-17 0 915 2018-08-08
291 °­¿ø °­¿øµµÀÇ»çȸ ÀúÇ÷´çÁõ¿¡ ´ëÇÑ °íÂû : 2018-08-16 0 553 2018-08-08
290 ¼­¿ï ´ëÇѽÅÀåÇÐȸ 2018 Update on CKD-MBD: Phosphorous and Magnesium in health and disease : 2018-09-30 0 1,150 2018-07-28
289 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø °³¿øÀǸ¦ À§ÇÑ ¼Ò¾ÆÁúȯ : 2018-09-29 0 856 2018-07-28
288 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ¿¬±Ø¼º ÀΰÝÀå¾Ö, ÀÇÁ¸¼º ÀΰÝÀå¾Ö : 2018-09-29 0 1,235 2018-07-28
287 ¼­¿ï 2018 ´ëÇÑâ»óÇÐȸ ±³À°½ÉÆ÷Áö¾ö : 2018-09-29 0 621 2018-07-28
286 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª(CSC treatment update) : 2018-09-28 0 1,103 2018-07-28
285 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø 1) ÇǺΠÇ÷°ü Áúȯ 2) »ö¼Ò ÀÌ»óÁõ : 2018-09-27 0 775 2018-07-28
284 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª(Æó¼â°¢ ³ì³»Àå) : 2018-09-21 0 1,427 2018-07-28
283 ´ë±¸ ´ëÇѽÅÀåÇÐȸ ´ë±¸-°æºÏÁöȸ ¿¬¼ö °­Á : 2018-09-20 0 668 2018-07-28
282 ¼­¿ï °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2018-09-20 0 393 2018-07-28
281 ¼­¿ï [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] 4Â÷ »ê¾÷Çõ¸í°ú ÀÇ·áÀÇ ¹Ì·¡ : 2018-09-20 0 644 2018-07-28
280 ¼­¿ï ¼­¿ïƯº°½ÃÀÇ»çȸ Á¦5Â÷ ȸ¿ø¿¬¼ö±³À°(Áø´Ü¸í¿¡ µû¸¥ ÀûÀýÇÑ Ã³¹æ) : 2018-09-20 0 852 2018-07-28
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷